A Study of High Risk Localized Prostate Cancer Participants Treated With Radical Prostatectomy and Perioperative Hormonal Therapy

CompletedOBSERVATIONAL
Enrollment

221

Participants

Timeline

Start Date

August 24, 2022

Primary Completion Date

June 7, 2023

Study Completion Date

June 7, 2023

Conditions
High Risk Localized Prostate Cancer
Trial Locations (9)

333

Chang Gung Memorial Hospital, Taoyuan

010-8543

Akita University Hospital, Akita

036-8563

Hirosaki University Hospital, Hirosaki

467-8602

Nagoya City University Hospital, Nagoya

236-0004

Yokohama City University Hospital, Yokohama

238-8558

Yokosuka Kyosai Hospital, Yokosuka

03722

Severance Hospital Yonsei University Health System, Seoul

06351

Samsung Medical Center, Seoul

06591

Catholic Medical Center, Seoul

All Listed Sponsors
lead

Johnson & Johnson International (Singapore) Pte. Ltd.

INDUSTRY